Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_assertion type Assertion NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_head.
- NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_assertion description "[Inhibitors of the tyrosine kinase receptors, such as IGF-1R, c-kit, PDGFR, VEGFR, or the mTOR signaling pathway, proteasome, angiogenesis, and stress response proteins are under clinical evaluation against sarcomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_provenance.
- NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_assertion evidence source_evidence_literature NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_provenance.
- NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_assertion SIO_000772 19013896 NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_provenance.
- NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_assertion wasDerivedFrom befree-2016 NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_provenance.
- NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_assertion wasGeneratedBy ECO_0000203 NP703921.RAOogpZgQkWdSIEF-Yf2reqTJCEqYp5pPtQcq2v1Hbxdg130_provenance.